SUPPLEMENTAL TABLES.docx (46.19 kB)
Download fileSupplementary Tables – A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer
dataset
posted on 2022-05-25, 08:48 authored by Figshare Future Science GroupFigshare Future Science Group, Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno, Tomoko Sugihara, Zhanglin Lin Cui, Kimberley T Lee
Table S1. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models Comparing High-risk Group with Node Negative Group (n=3424)
Table S2. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models for US FDA-approved Indicated Patient Subgroup Compared with Non-high-risk Group (n=3607)
Table S3. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)
Table S4. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)
